The 4th ’EyeCan’ focused on cutting-edge advancements in ocular oncology, particularly complex surgical reconstruction and emerging immunotherapy for ophthalmic tumors. Highlights included techniques for optimal patient outcomes, best practices for new ocular oncology practices, and insights from three renowned faculty on the latest trends.
Share this Post:
